다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Immunity, v.9 no.3, 1998년, pp.405 - 411
Caldwell, Robert G (Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611, USA) , Wilson, Joanna B (Division of Molecular Genetics, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G11 6NU, United Kingdom) , Anderson, Steven J (Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611, USA) , Longnecker, Richard (Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611, USA)
AI-Helper
AbstractEpstein-Barr virus (EBV) establishes a persistent latent infection in peripheral B lymphocytes in humans and is associated with a variety of malignancies and proliferative disorders. Latent membrane protein 2A (LMP2A) is one of only two viral proteins expressed in latently infected B lymphoc...
Immunity Babcock 9 395 1998 10.1016/S1074-7613(00)80622-6 EBV persistence in memory B cells in vivo
Proc. Natl. Acad. Sci. USA Braeuninger 94 9337 1997 10.1073/pnas.94.17.9337 Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells
J. Virol Burkhardt 66 5161 1992 10.1128/JVI.66.8.5161-5167.1992 An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases
J. Virol Chen 69 3752 1995 10.1128/JVI.69.6.3752-3758.1995 A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
Nature Cheng 378 303 1995 10.1038/378303a0 Syk tyrosine kinase required for mouse viability and B-cell development
Proc. Natl. Acad. Sci. USA Dush 82 2731 1985 10.1073/pnas.82.9.2731 Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene
EMBO J Era 10 337 1991 10.1002/j.1460-2075.1991.tb07954.x Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin
J. Virol Fruehling 70 6216 1996 10.1128/JVI.70.9.6216-6226.1996 Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
Virology Fruehling 235 241 1997 10.1006/viro.1997.8690 The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction
Proc. Natl. Acad. Sci. USA Gratama 85 8693 1988 10.1073/pnas.85.22.8693 Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation
Cell Grosschedl 41 885 1985 10.1016/S0092-8674(85)80069-6 Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements
Hogan 1994 Manipulating the Mouse Embryo
J. Exp. Med Kanzler 184 1495 1996 10.1084/jem.184.4.1495 Hodgkin and Reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
Nature Katamine 309 369 1984 10.1038/309369a0 Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements
Kieff, E. (1996). Epstein-Barr virus and its replication. In Fundamental Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven), pp. 1109-1162.
Nature Kitamura 350 423 1991 10.1038/350423a0 A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
Cell Lam 90 1073 1997 10.1016/S0092-8674(00)80373-6 In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
Lancet Lam 337 876 1991 10.1016/0140-6736(91)90203-2 Circulating Epstein-Barr virus-carrying B cells in acute malaria
Int. J. Cancer Lewin 39 472 1987 10.1002/ijc.2910390411 Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth
J. Virol Longnecker 64 2319 1990 10.1128/JVI.64.5.2319-2326.1990 A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1
Trends Microbiol Longnecker 4 38 1996 10.1016/0966-842X(96)81504-6 Regulation of Epstein-Barr virus latency by latent membrane protein 2
J. Virol Longnecker 65 3681 1991 10.1128/JVI.65.7.3681-3692.1991 An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase
J. Virol Longnecker 66 6461 1992 10.1128/JVI.66.11.6461-6469.1992 The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential
J. Virol Longnecker 67 2006 1993 10.1128/JVI.67.4.2006-2013.1993 The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro
J. Virol Longnecker 67 5068 1993 10.1128/JVI.67.8.5068-5074.1993 Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
J. Virol Marchini 67 606 1993 10.1128/JVI.67.1.606-609.1993 Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line
J. Virol Miller 67 3087 1993 10.1128/JVI.67.6.3087-3094.1993 Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes
Proc. Natl. Acad. Sci. USA Miller 91 772 1994 10.1073/pnas.91.2.772 An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking
Immunity Miller 2 155 1995 10.1016/S1074-7613(95)80040-9 Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
Cell Miyashita 80 593 1995 10.1016/0092-8674(95)90513-8 A novel form of Epstein-Barr virus latency in normal B cells in vivo
J. Virol Miyashita 71 4882 1997 10.1128/JVI.71.7.4882-4891.1997 Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
Cell Mombaerts 68 869 1992 10.1016/0092-8674(92)90030-G RAG-1-deficient mice have no mature B and T lymphocytes
J. Virol Qu 66 3715 1992 10.1128/JVI.66.6.3715-3724.1992 Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes
Rickinson, A.B., and Kieff, E. (1996). Epstein-Barr virus. In Fields Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Philadelphia, PA: Lippincott-Raven), pp. 2397-2446.
Cell Rolink 66 1081 1991 10.1016/0092-8674(91)90032-T Molecular and cellular origins of B lymphocyte diversity
Cell Schlissel 58 1001 1989 10.1016/0092-8674(89)90951-3 Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription
J. Exp. Med Schlissel 173 711 1991 10.1084/jem.173.3.711 Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription
Cell Shinkai 68 855 1992 10.1016/0092-8674(92)90029-C RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
Genes Dev Spanopoulou 8 1030 1994 10.1101/gad.8.9.1030 Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice
J. Immunol Takahama 154 5862 1995 10.4049/jimmunol.154.11.5862 Regulation of early T cell development by the engagement of TCR-β complex expressed on fetal thymocytes from TCR-β-transgenic scid mice
J. Virol Tierney 68 7374 1994 10.1128/JVI.68.11.7374-7385.1994 Epstein-Barr virus latency in blood mononuclear cells
Nature Turner 378 298 1995 10.1038/378298a0 Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
Int. J. Cancer Yao 35 35 1985 10.1002/ijc.2910350107 A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals
Int. J. Cancer Yao 43 67 1989 10.1002/ijc.2910430115 Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers
Int. J. Cancer Yao 48 253 1991 10.1002/ijc.2910480217 Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.